Sean C. Flynn
Net Worth
Last updated:
What is Sean C. Flynn net worth?
The estimated net worth of Mr. Sean C. Flynn is at least $4,313,236 as of 16 Jul 2024. He owns shares worth $25,572 as insider, has earned $2,276,904 from insider trading and has received compensation worth at least $2,010,760 in Vericel Corporation and Verastem, Inc..
What is the salary of Sean C. Flynn?
Mr. Sean C. Flynn salary is $502,690 per year as Vice President, Gen. Counsel & Sec. in Vericel Corporation.
How old is Sean C. Flynn?
Mr. Sean C. Flynn is 51 years old, born in 1974.
What stocks does Sean C. Flynn currently own?
As insider, Mr. Sean C. Flynn owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Vericel Corporation (VCEL) | Vice President, Gen. Counsel & Sec. | 707 | $36.17 | $25,572 |
What does Vericel Corporation do?
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Sean C. Flynn insider trading
Vericel Corporation
Mr. Sean C. Flynn has made 10 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 15,000 units of VCEL stock worth $782,700 on 16 Jul 2024.
The largest trade he's ever made was exercising 15,000 units of VCEL stock on 16 Jul 2024. As of 16 Jul 2024 he still owns at least 707 units of VCEL stock.
Vericel key executives
Vericel Corporation executives and other stock owners filed with the SEC:
- Dr. Jonathan M. Hopper (63) Chief Medical Officer
- Mr. Dominick C. Colangelo Esq. (61) Chief Executive Officer, Pres & Director
- Mr. Michael Halpin (64) Chief Operating Officer
- Mr. Sean C. Flynn (51) Vice President, Gen. Counsel & Sec.